MK0493

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK0493, covering 2015-04-28 to 2019-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED) [Phase 2]